D. Treille

812 citations
13 papers · 687 indexed · h-index 8

D. Treille

13 papers receiving 663 citations

Peers

D. Treille
Comparison fields: 5 of 50
  • Hematology 372
  • Oncology 386
  • Genetics 102
  • Public Health, Environmental and Occupational Health 169
  • Infectious Diseases 76
Replace IM Chen with:
IM Chen United States
P Calmard-Oriol France
DR Head United States
O. A. Haas Austria
Germano Aronica Italy
Bortin Mm United States
Paola Carluccio Italy
MM Oken United States
Craig Howe United States
Simona Lapusan France
D. Treille relative to IM Chen United States IM Chen's profile →
Citations per field
00.5×2.5×
IM Chen · 1×
Citations per year

Countries citing papers authored by D. Treille

Since Specialization
Citations

This map shows the geographic impact of D. Treille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Treille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Treille more than expected).

Fields of papers citing papers by D. Treille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Treille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Treille. The network helps show where D. Treille may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Treille, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Treille Line = papers co-authored together D. Treille links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 199217
2 19921
3 199231
4 19925
5 1992426
6 19929
7 19927
8
Myeloid surface antigen expression in adult acute lymphoblastic leukemia.
199051
9 1989116
10 19885
11 19879
12
[Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].
19823
13
Prognostic value of mouse red cell rosette formation in chronic lymphocytic leukaemia.
19767

About D. Treille

D. Treille is a scholar working on Hematology, Emergency Medicine and Immunology, having authored 13 papers that have together received 687 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Hematological disorders and diagnostics (2 papers), Advanced Biosensing Techniques and Applications (1 paper), T-cell and Retrovirus Studies (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (372 citations), Oncology (386 citations) and Genetics (102 citations). D. Treille has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Denis Guyotat, Lydia Campos, D Fière, E Archimbaud, P Calmard-Oriol, Jacques Troncy, T Tsuruo, O Gentilhomme, A. Larèse and Jean Maupas. Their work appears in journals such as Blood, European Journal Of Haematology, Annals of Hematology, Acta Haematologica and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026